Archean Chemical’s Q3FY23 EBITDA grew 36% YoY to Rs1.6bn, a tad lower than our expectation due to lower bromine volumes, which indeed were hurt from lower off-take by Chinese. It was compensated by higher industrial salt volumes and improved realisations for both bromine and industrial salts.